HYAL4 V1
|
Bladder Cancer
|
HYAL4 V1
|
Bladder Cancer
|
gemcitabine Resistant: D – Preclinical
|
gemcitabine Resistant: D – Preclinical
|
HYAL4 V1
|
Bladder Cancer
|
HYAL4 V1
|
Bladder Cancer
|
gemcitabine + EPI01 Sensitive: D – Preclinical
|
gemcitabine + EPI01 Sensitive: D – Preclinical
|